Literature DB >> 22144478

Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis.

Roger G Rank1, Anne K Bowlin, Kati I Tormanen, Yin Wang, Anthony T Maurelli.   

Abstract

In order to study the interaction of variants in in vivo infection, we employed an azithromycin-resistant mutant (AZ(2)) and its wild-type parent (SP(6)) in the guinea pig model of Chlamydia caviae conjunctival infection. When each strain was inoculated individually into conjunctiva, both attained the same level of growth, but AZ(2) elicited less pathology. However, when equal numbers of the two strains were inoculated together into the guinea pig conjunctiva, SP(6) produced a significantly greater number of inclusion-forming units than AZ(2), and the pathology reflected that of a SP(6) monoinfection. The goal of this study was to further characterize the dynamics of concomitant infection of these two distinct variants, with particular emphasis on the impact of the host response on the in vivo growth of each organism and the development of pathology. Animals infected with AZ(2) had reduced conjunctival infiltration with CD45(+) cells and neutrophils as well as a reduced interleukin-8 (IL-8) response. Gene expression of gamma interferon (IFN-γ), tumor necrosis factor alpha (TNF-α), CCL2, and CCL5 was also significantly lower in AZ(2)-infected animals. The lower inflammatory response induced by AZ(2) was associated with its decreased ability to activate NF-κB via Toll-like receptor 2 (TLR2). In general, the inflammatory response in animals infected with both variants was greater than in infection with AZ(2) alone, resulting in lower numbers of AZ(2) than those of SP(6) in the mixed infection. Our results suggest that the ability to elicit an inflammatory response is an important factor in the dynamics of mixed infection with strains that display different pathological phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144478      PMCID: PMC3264299          DOI: 10.1128/IAI.06054-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity.

Authors:  Isao Miyairi; Jonathan D Laxton; Xiaofei Wang; Caroline A Obert; Venkat R R Arva Tatireddigari; Nico van Rooijen; Thomas P Hatch; Gerald I Byrne
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

2.  Local host response to chlamydial urethral infection in male guinea pigs.

Authors:  Yin Wang; Uma Nagarajan; Leah Hennings; Anne K Bowlin; Roger G Rank
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

3.  The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Authors:  John H Carlson; William M Whitmire; Deborah D Crane; Luke Wicke; Kimmo Virtaneva; Daniel E Sturdevant; John J Kupko; Stephen F Porcella; Neysha Martinez-Orengo; Robert A Heinzen; Laszlo Kari; Harlan D Caldwell
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

4.  Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.

Authors:  Toni Darville; Joshua M O'Neill; Charles W Andrews; Uma M Nagarajan; Lynn Stahl; David M Ojcius
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

5.  Strain and virulence diversity in the mouse pathogen Chlamydia muridarum.

Authors:  Kyle H Ramsey; Ira M Sigar; Justin H Schripsema; Cecele J Denman; Anne K Bowlin; Garry A S Myers; Roger G Rank
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

6.  Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs.

Authors:  Rachel Binet; Anne K Bowlin; Anthony T Maurelli; Roger G Rank
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

7.  Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chlamydial infection.

Authors:  Roger G Rank; Judy Whittimore; Anne K Bowlin; Sophie Dessus-Babus; Priscilla B Wyrick
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-24

8.  Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes.

Authors:  Kim Millman; Carolyn M Black; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  Microbes Infect       Date:  2006-01-05       Impact factor: 2.700

9.  Systemic immunization with Hsp60 alters the development of chlamydial ocular disease.

Authors:  R G Rank; C Dascher; A K Bowlin; P M Bavoil
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-06       Impact factor: 4.799

10.  Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations.

Authors:  Laszlo Kari; William M Whitmire; John H Carlson; Deborah D Crane; Nathalie Reveneau; David E Nelson; David C W Mabey; Robin L Bailey; Martin J Holland; Grant McClarty; Harlan D Caldwell
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

View more
  5 in total

1.  Chlamydial variants differ in ability to ascend the genital tract in the guinea pig model of chlamydial genital infection.

Authors:  Laxmi Yeruva; Anne K Bowlin; Nicole Spencer; Anthony T Maurelli; Roger G Rank
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

2.  Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.

Authors:  Jennifer R Carmichael; Delia Tifrea; Sukumar Pal; Luis M de la Maza
Journal:  Microbes Infect       Date:  2012-12-31       Impact factor: 2.700

3.  Kinetics of Local and Systemic Leucocyte and Cytokine Reaction of Calves to Intrabronchial Infection with Chlamydia psittaci.

Authors:  Annette Prohl; Katharina Wolf; Corinna Weber; Kerstin E Müller; Christian Menge; Konrad Sachse; Jürgen Rödel; Petra Reinhold; Angela Berndt
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

4.  Early microRNA expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a mouse model of chlamydial genital infection.

Authors:  Laxmi Yeruva; Garry S A Myers; Nicole Spencer; Heather Huot Creasy; Nancy E Adams; Anthony T Maurelli; Grant R McChesney; Mario A Cleves; Jacques Ravel; Anne Bowlin; Roger G Rank
Journal:  mBio       Date:  2014-06-24       Impact factor: 7.867

5.  Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011.

Authors:  Erik D Cram; Daniel D Rockey; Brian P Dolan
Journal:  BMC Microbiol       Date:  2017-04-24       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.